Biogen Was The Train Wreck Everyone Saw Coming: Nisen (Podcast)
Max Nisen, Bloomberg Opinion health care columnist, on Biogen plunging after the company and its partner Eisai announced it was halting their Alzheimer drug trial. Gad Levanon, Chief Economist: North ...
21 Maalis 201926min
TCW's Rivelle: Cautious on EM Debt This Late In Cycle
Tad Rivelle, Chief Investment Officer for Fixed Income at TCW Group, on the credit markets, the Fed, and current investment strategy. Frank Sorrentino, CEO of ConnectOne Bank, on why the U.S. economy ...
20 Maalis 201929min
Brexit's Monty Python Impression Continues: Authers
John Authers, Senior Editor for Bloomberg Markets, on the Monty Python circus that is Brexit. Brent Bell, VP of Recycling at Waste Management, on how China has stopped accepting our trash. Eric Larche...
19 Maalis 201929min
Max Grounding Will Cost Boeing $100 Million Per Month (Podcast)
Peter Robison, Bloomberg investigations reporter, and George Ferguson, Senior Aerospace and Airline Analyst for Bloomberg Intelligence, on how Boeing had too much sway in vetting its own jets. Atish D...
18 Maalis 201927min
We Won’t Get the Earnings Jolt Like in 2018 (Podcast)
Joining on today's conversation is Matt Forester, BNY Mellon's Lockwood CIO, on markets and investing. Also joining today is Benedikt Kammel, Bloomberg Senior Editor for Company News, on the latest on...
15 Maalis 201925min
The Commercial Real Estate Market is in Good Shape
Joining in on today's conversation is John Butler, North American Telecoms Reporter, on Direct TV rate hikes and the changes of consumer viewing habits. We also have John Pearson, CEO of DHL Express,...
14 Maalis 201919min
If You Have Money in the Market, Stay with the Market (Podcast)
On today’s show we have Janet Lorin, Bloomberg Endowments Reporter, on the latest on the college scandal bribes. Also joining is Ben Emons, Managing Director: Global Macro Strategy at Medley Global A...
13 Maalis 201933min
Making Voting Easy for Military and Partial Disabilities (Podcast)
Joining in studio is Max Nisen, Bloomberg Opinion Pharm and Health Care Columnist on Health care costs on big companies like Ford. Also joining in studio is Joel Stern, Chairman and CEO of Stern Value...
12 Maalis 201927min
